Clopidogrel is indicated for the reduction
of thrombotic events in patients with recent myocardial infarction,
recent stroke, or established peripheral arterial disease.
It is used prophylactically in patients at risk of thromboembolic
disorders such as myocardial infarction, peripheral arterial
disease and stroke. It is also indicated for the acute coronary
syndrome (unstable angina/non-Q-wave MI).
Norplat (clopidogrel) is an inhibitor of ADP-
induced platelet aggregation. It reduces the chance of having
a heart attack or a stroke in people who have already had
a heart attack or a stroke.